Cority Streamlines Incident Management for Class II Railroads in the United States
Nov 02, 2017 12:01 pm UTC| Business
Toronto, Canada, Nov. 02, 2017 -- Cority, the most trusted Environmental, Health, Safety and Quality (EHSQ) software for assuring client success, today announced enhancements to its Incident Management solution to...
II-VI Incorporated to Present at Upcoming Investor Conferences
Nov 02, 2017 12:01 pm UTC| Business
PITTSBURGH, Nov. 02, 2017 -- II-VI Incorporated (NASDAQ:IIVI), a leader in engineered materials and optoelectronic components, today announced that Dr. Vincent D. Mattera, Jr., President and Chief Executive Officer, and...
Nov 02, 2017 12:01 pm UTC| Business
LONDON, Nov. 02, 2017 -- Bromium®, Inc., the pioneer and leader in virtualisation-based enterprise security that stops advanced malware attacks, today announced that the Metropolitan Police Cybercrime Unit (FALCON) has...
Grand Rounds Survey: Do Consumers Care About Physician Quality?
Nov 02, 2017 12:01 pm UTC| Business
WASHINGTON, Nov. 02, 2017 -- Grand Rounds, a San Franciso-based health technology company, today released survey findings at the US News World Report Healthcare of Tomorrow conference in Washington, D.C. Survey...
Duluth Holdings Celebrates Grand Opening of its Twenty-Seventh Store in Louisville, Kentucky
Nov 02, 2017 12:01 pm UTC| Business
BELLEVILLE, Wis., Nov. 02, 2017 -- Duluth Holdings Inc. (dba, Duluth Trading Company) (“Duluth Trading”) (NASDAQ:DLTH), a lifestyle brand of men’s and women’s casual wear, workwear and accessories, today announced the...
Nov 02, 2017 12:00 pm UTC| Business
MORRIS PLAINS, N.J., Nov. 02, 2017 -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or the “Company”) today announced that it will host a conference call on Thursday, November 9, 2017 at 5:00 p.m. Eastern Time to...
Progenics Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Update
Nov 02, 2017 12:00 pm UTC| Business
NDA (New Drug Application) for AZEDRA® (iobenguane I 131) Submitted to the U.S. Food and Drug Administration (FDA) on October 31stPositive Results from the Pivotal Phase 2b Study of AZEDRA Highlighted at Multiple Medical...